Vivo Bio tech Ltd. has reported financial results for the period ended June 30, 2021.
Financial Results (Q1 FY 2021-22) - QoQ Comparison
The company has reported total income of Rs.13.21 crores during the period ended June 30, 2021 as compared to Rs.16.15 crores during the period ended March 31, 2021.
The company has posted net profit / (loss) of Rs.1.23 crores for the period ended June 30, 2021 as against net profit / (loss) of Rs.0.2975 crores for the period ended March 31, 2021.
The company has reported EPS of Rs.0.84 for the period ended June 30, 2021 as compared to Rs.0.22 for the period ended March 31, 2021.
|
Total Income | ₹ 13.21 crs | ₹ 16.15 crs | -18.2% |
Net Profit | ₹ 1.23 crs | ₹ 0.2975 crs | 313.45% |
EPS | ₹ 0.84 | ₹ 0.22 | 281.82% |
Financial Results (Q1 FY 2021-22) - YoY ComparisonThe company has reported total income of Rs.13.21 crores during the period ended June 30, 2021 as compared to Rs.9.18 crores during the period ended June 30, 2020.
The company has posted net profit / (loss) of Rs.1.23 crores for the period ended June 30, 2021 as against net profit / (loss) of Rs.0.9776 crores for the period ended June 30, 2020.
The company has reported EPS of Rs.0.84 for the period ended June 30, 2021 as compared to Rs.0.76 for the period ended June 30, 2020.
|
Total Income | ₹ 13.21 crs | ₹ 9.18 crs | 43.9% |
Net Profit | ₹ 1.23 crs | ₹ 0.9776 crs | 25.82% |
EPS | ₹ 0.84 | ₹ 0.76 | 10.53% |
Shares of Vivo Bio tech Ltd. was last trading in BSE at Rs. 81.45 as compared to the previous close of Rs. 81.35. The total number of shares traded during the day was 12627 in over 153 trades.
The stock hit an intraday high of Rs. 86 and intraday low of 80.5. The net turnover during the day was Rs. 1049917.
Source : Equity Bulls
Keywords